Versor Investments’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-2,500
Closed -$382K 798
2025
Q2
$382K Sell
2,500
-180
-7% -$27.7K 0.07% 468
2025
Q1
$444K Buy
+2,680
New +$419K 0.07% 442
2023
Q4
Sell
-2,700
Closed -$421K 782
2023
Q3
$421K Buy
+2,700
New +$446K 0.09% 374
2021
Q4
Sell
-6,845
Closed -$1.1M 594
2021
Q3
$1.1M Buy
+6,845
New +$1.17M 0.03% 99
2021
Q2
Sell
-1,807
Closed -$297K 373
2021
Q1
$297K Buy
+1,807
New +$292K 0.02% 188
2020
Q3
Sell
-4,895
Closed -$688K 310
2020
Q2
$688K Sell
4,895
-577
-11% -$84.1K 0.07% 54
2020
Q1
$718K Buy
5,472
+3,972
+265% +$564K 0.05% 80
2019
Q4
$219K Buy
+1,500
New +$203K 0.01% 285
2019
Q3
Sell
-17,366
Closed -$2.42M 314
2019
Q2
$2.42M Buy
17,366
+1,900
+12% +$263K 0.16% 85
2019
Q1
$2.16M Buy
15,466
+12,166
+369% +$1.63M 0.21% 51
2018
Q4
$426K Buy
+3,300
New +$460K 0.1% 182

Other funds holding JNJ

Versor Investments's JNJ Position: Q3 2025 in Review

Versor Investments sold out of Johnson & Johnson (JNJ) in Q3 2025, closing a stake of 2,500 shares — an estimated $382K sold.

Versor Investments first reported a position in JNJ in Q4 2018 and held it in 11 quarters. The position peaked at $2.42M in Q2 2019. 4,187 funds tracked by Wall St. Rank hold JNJ as of Q3 2025.

  • Versor Investments reported no remaining Johnson & Johnson position as of Q3 2025 after selling out during the quarter.
  • Versor Investments sold 2,500 Johnson & Johnson shares in Q3 2025, an estimated $382K.
  • Versor Investments first reported a position in Johnson & Johnson in Q4 2018 and held it in 11 quarters.
  • Versor Investments's Johnson & Johnson position peaked at $2.42M in Q2 2019.
  • 4,187 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2025.

Based on Versor Investments's 13F filing for Q3 2025, filed 6 Nov 2025.